Original Article
Copyright ©2012 Baishideng Publishing Group Co.
World J Gastroenterol. Dec 28, 2012; 18(48): 7251-7261
Published online Dec 28, 2012. doi: 10.3748/wjg.v18.i48.7251
Table 3 The correlation between the genotype of CDH17 gene c.2216A>C and clinicopathologic parameters in colorectal carcinomas n (%)
Clinicopathologic parametersnGenotype CDH17 c.2216A>Gχ2P value
A/AA/CC/C
Gender
Male4720 (42.6)5 (10.6)22 (46.8)3.6560.161
Female4611 (23.9)7 (15.2)28 (60.9)
Age (yr)
< 50296 (20.7)5 (17.2)18 (62.1)3.1760.204
≥ 506425 (39.1)7 (10.9)32 (50.0)
Tumor location
Colon3210 (31.3)6 (18.8)16 (50.0)1.4850.476
Rectum6121 (34.4)6 (9.8)34 (55.7)
Tumor size (cm)
< 56825 (36.8)5 (7.4)38 (55.9)7.1440.0283
≥ 5256 (24.0)7 (28.0)12 (48.0)
Macroscopic appearance
Protrude type3111 (35.5)4 (12.9)16 (51.6)1.0250.9061
Ulcer type4616 (34.8)5 (10.9)25 (54.3)
Infiltrating type164 (25.0)3 (18.8)9 (56.3)
Colloid type00 (0.0)0 (0.0)0 (0.0)
Histologic type
Adenocarcinoma7123 (32.4)10 (14.1)38 (53.5)1.6840.7941
Adenocarcinoma and mucinous carcinoma94 (44.4)0 (0.0)5 (55.6)
Mucinous carcinoma134 (30.8)2 (15.4)7 (53.8)
Undifferentiated carcinoma00 (0.0)0 (0.0)0 (0.0)
Adenosquamous carcinoma00 (0.0)0 (0.0)0 (0.0)
Squamous cell carcinoma00 (0.0)0 (0.0)0 (0.0)
Invasion depth
Submucosa22 (100.0)0 (0.0)0 (0.0)1.6100.4472
Muscular layer3412 (35.3)4 (11.8)18 (52.9)
Serous coat4814 (29.2)5 (10.4)29 (60.4)
Other organs93 (33.3)3 (33.3)3 (33.3)
Differentiation degree
Well-differentiated40 (0.0)0 (0.0)4 (100.0)0.0900.9562
Moderately-differentiated6324 (38.1)9 (14.3)30 (47.6)
Poorly-differentiated267 (26.9)3 (11.5)16 (61.5)
Lymph node metastasis
No5925 (42.4)10 (16.9)24 (40.7)11.1430.0043
Yes346 (17.6)2 (5.9)26 (76.5)
TNM grade
I2612 (46.2)4 (15.4)10 (38.5)6.7100.03523
II3112 (38.7)5 (16.1)14 (45.2)
III336 (18.2)2 (6.1)25 (75.8)
IV31 (33.3)1 (33.3)1 (33.3)
Hematogenous metastasis
No9030 (33.3)11 (12.2)49 (54.4)1.2430.5371
Yes31 (33.3)1 (33.3)1 (33.3)
Recurrence
No9129 (31.9)12 (13.2)50 (54.9)4.0880.1301
Yes22 (100.0)0 (0.0)0 (0.0)